NASDAQ$HWKN
Hawkins Inc · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
Hawkins reported record second quarter performance with sales, gross profit, operating income, net income and EPS increasing year-over-year.
Hawkins, Inc. announced record second quarter fiscal 2023 results, with sales increasing by 32% year-over-year. The company reported growth across all three reporting segments, driven primarily by price increases. EPS increased by 28% compared to the same period last year.
- Record second quarter performance for sales, gross profit, operating income, net income, and EPS.
- Sales increased by 32% year-over-year, with growth in all three reporting segments.
- Gross profit increased by 24% year-over-year, contributing to a 35% increase in operating income.
- EPS increased by 28% compared to the same period last year.
Headline financials
Revenue & EPS history
Hawkins · Revenue · Quarterly
$241M
Revenue by segment
Hawkins · $241M total across 3 segments · Q2 2023
- Industrial Solutions$114M+37.0%47.2%
- Water Treatment$86.5M+39.2%35.9%
- Food & Health Sciences$40.8M+7.3%16.9%
Forward guidance
Looking to the third quarter, one of our large suppliers recently had an unplanned shut down which has put additional cost pressures on us, as we secure product from other sources to allocate to our customers. In addition, we are starting to see softness in the Health and Nutrition segment, and we expect significant LIFO expenses to continue in the third quarter. These items will impact the third quarter negatively and we expect it to cause EPS to be relatively flat when compared to the prior year. We expect supply to return to normal by the fourth quarter.
Tailwinds
- Expect top-line growth to continue in all segments.
- Growing both organically and through acquisitions in future years.
- Focus on the long-term.
- Expect supply to return to normal by the fourth quarter.
- Continued growth in Industrial and Water Treatment segments.
Headwinds
- Unplanned supplier shutdown putting additional cost pressures.
- Softness in the Health and Nutrition segment.
- Expect significant LIFO expenses to continue in the third quarter.
- These items will impact the third quarter negatively.
- Expect it to cause EPS to be relatively flat when compared to the prior year.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2023
+0.7%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+5.6%
Avg return
30 days after
56%
36 / 64 earnings
Positive
+17.6%
Q1 2025
Best reaction
-10.2%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | -3.2% | -5.5% | -2.1% | |
| Q3 2026 | -9.1% | -17.6% | -3.0% | |
| Q2 2026 | -5.0% | -19.0% | -18.0% | |
| Q4 2025 | -0.7% | +5.8% | +13.5% | |
| Q3 2025 | -8.4% | -0.1% | -9.6% | |
| Q2 2025 | -8.8% | -9.3% | +14.8% | |
| Q1 2025 | +17.6% | +11.1% | +22.8% | |
| Q4 2024 | +9.4% | +15.4% | +13.1% | |
| Q3 2024 | -10.2% | -13.5% | +1.7% | |
| Q2 2024 | -5.1% | +5.8% | +9.0% | |
| Q1 2024 | +7.1% | +10.2% | +35.9% | |
| Q4 2023 | +12.3% | +9.1% | +15.4% | |
| Q3 2023 | +9.8% | +5.5% | +8.1% | |
| Q2 2023 | -2.3% | -9.5% | -9.6% | |
| Q1 2023 | +3.9% | +7.4% | -1.7% | |
| Q4 2022 | -7.5% | -10.5% | -7.2% | |
| Q3 2022 | +9.4% | +5.8% | +23.9% | |
| Q2 2022 | -7.1% | -4.7% | -11.6% | |
| Q1 2022 | +14.9% | +12.4% | +22.3% | |
| Q4 2021 | +4.0% | +2.5% | -0.3% | |
| Q3 2021 | +9.7% | +11.5% | +25.1% | |
| Q2 2021 | +3.8% | -5.8% | +2.6% | |
| Q1 2021 | +2.1% | +8.7% | +7.5% | |
| Q4 2020 | +9.3% | +14.9% | +11.0% | |
| Q3 2020 | +0.7% | +0.9% | -6.7% | |
| Q2 2020 | +4.0% | +7.9% | +0.6% | |
| Q1 2020 | +0.5% | +3.9% | -1.3% | |
| Q4 2019 | +4.5% | +4.1% | +15.5% | |
| Q3 2019 | -10.1% | -14.2% | -7.4% | |
| Q2 2019 | +10.5% | +9.0% | +22.9% | |
| Q1 2019 | +9.8% | +9.2% | +10.7% | |
| Q4 2018 | -6.9% | -3.1% | +4.9% | |
| Q3 2018 | +3.2% | +5.7% | +5.7% | |
| Q2 2018 | -2.4% | -5.9% | -1.0% | |
| Q1 2018 | -4.4% | -7.0% | -15.6% | |
| Q4 2017 | +1.4% | +1.6% | -1.1% | |
| Q3 2017 | +0.5% | +2.0% | -4.6% | |
| Q2 2017 | +0.7% | +3.8% | +21.6% | |
| Q1 2017 | +2.4% | +4.0% | +4.3% | |
| Q4 2016 | +10.5% | +12.2% | +11.3% | |
| Q3 2016 | +0.3% | — | — | |
| Q2 2016 | +1.1% | — | — | |
| Q1 2016 | +0.3% | — | — | |
| Q4 2015 | +2.2% | — | — | |
| Q3 2015 | -2.4% | — | — | |
| Q2 2015 | +2.5% | — | — | |
| Q1 2015 | -2.0% | — | — | |
| Q4 2014 | -1.8% | — | — | |
| Q3 2014 | -2.0% | — | — | |
| Q2 2014 | -5.5% | — | — | |
| Q1 2014 | -6.6% | — | — | |
| Q4 2013 | -1.8% | — | — | |
| Q3 2013 | +0.3% | — | — | |
| Q2 2013 | +0.8% | — | — | |
| Q1 2013 | +1.9% | — | — | |
| Q4 2010 | -3.1% | — | — | |
| Q4 2012 | -3.1% | — | — | |
| Q3 2011 | +3.2% | — | — | |
| Q3 2012 | +3.2% | — | — | |
| Q2 2012 | +2.5% | — | — | |
| Q1 2012 | -3.3% | — | — | |
| Q1 2011 | -3.3% | — | — | |
| Q2 2011 | -3.3% | — | — | |
| Q4 2011 | -3.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro